Cancer Drug Discovery: Fascinating Anecdotes of Oncology Medicine
暫譯: 癌症藥物發現:腫瘤醫學的迷人轶事
Li, Jie Jack
- 出版商: CRC
- 出版日期: 2026-04-21
- 售價: $8,580
- 貴賓價: 9.5 折 $8,151
- 語言: 英文
- 頁數: 212
- 裝訂: Hardcover - also called cloth, retail trade, or trade
- ISBN: 1041248032
- ISBN-13: 9781041248033
尚未上市,無法訂購
商品描述
History is an erudite teacher, from which we can learn invaluable lessons, both positive and negative. This is especially true for drug discovery and development. While creativity demands we think outside of the box, past successes and failures in creating medicines are gifts that keep on giving. Creation of human medicines involves so many scientific and medical disciplines. History is our indispensable resource of institutional knowledge. This volume in a new series sheds light on successes to emulate and pitfalls to avoid in oncology drug discovery. The series editor blends education with engaging content for aspiring drug developers and helps to foster a deeper understanding.
Key Features
- It aims to integrate biology, chemistry, medicine, and history, which mirrors the multidisciplinary nature of drug development.
- By targeting the next generation drug developers and making efforts to include narrative and historical elements, it differentiates itself from pure technical texts.
- Using history to contextualize drug discovery helps readers to understand why certain strategies worked or failed.
- The inclusion of chemical structures in Chapter 8 makes the book more substantial for scientists with a chemistry background.
- The focus on novel approaches enhances the relevance of the book for the future.
商品描述(中文翻譯)
歷史是一位博學的老師,我們可以從中學到寶貴的教訓,無論是正面的還是負面的。這對於藥物發現和開發尤其如此。雖然創造力要求我們跳出框架思考,但過去在創造藥物方面的成功與失敗是持續提供啟示的禮物。人類藥物的創造涉及許多科學和醫學學科。歷史是我們不可或缺的機構知識資源。本書是新系列中的一部分,闡明了在腫瘤學藥物發現中值得效仿的成功案例和應避免的陷阱。系列編輯將教育與引人入勝的內容相結合,幫助有志於成為藥物開發者的人們加深理解。
主要特點
- 本書旨在整合生物學、化學、醫學和歷史,反映藥物開發的多學科特性。
- 針對下一代藥物開發者,並努力融入敘事和歷史元素,使其與純技術文本區別開來。
- 利用歷史為藥物發現提供背景,幫助讀者理解為何某些策略成功或失敗。
- 第八章中包含的化學結構使本書對具有化學背景的科學家更具實質性。
- 對新穎方法的關注增強了本書對未來的相關性。
作者簡介
Jie Jack Li is an established chemist with over 30 years of experience in both medicinal chemistry and process chemistry. He is also renowned as an author or co-author of 34 peer-reviewed articles, 12 patents, and 35 books. Dr. Li worked at Pfizer, BMS, and Revolution Medicines in oncology, antivirals, metabolic disease, CNS, anti-inflammatory, and dermatology, targeting enzymes, receptors and ion channels. Dr. Li was also a professor at the University of San Francisco for four years, teaching organic and medicinal chemistry. He earned his PhD from Indiana University and was a post-doctoral fellow at MIT.
作者簡介(中文翻譯)
李杰傑是一位資深的化學家,擁有超過30年的藥物化學和工藝化學經驗。他也是34篇經過同行評審的文章、12項專利和35本書籍的作者或合著者。李博士曾在輝瑞(Pfizer)、百時美施貴寶(BMS)和Revolution Medicines工作,專注於腫瘤學、抗病毒、代謝疾病、中樞神經系統、抗炎和皮膚科,針對酶、受體和離子通道進行研究。李博士還曾在舊金山大學擔任教授四年,教授有機化學和藥物化學。他在印第安納大學獲得博士學位,並在麻省理工學院(MIT)擔任博士後研究員。